Get started Log in

IFRX — Inflarx NV Share News

0.000.00%

Last trade - 00:00

FinancialsSpeculativeSmall CapMomentum Trap

Market Cap
$266.60m
Enterprise Value
$221.94m
Revenue
€0.03m

Brief: Inflarx N.V. Reports Third Quarter 2018 Financial & Operating Results
21/11/2018 13:41
NASDAQ RESUMED
19/11/2018 15:52
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE
19/11/2018 15:42
Brief: Inflarx Completes Enrollment In Phase IIb Clinical Trial With Lead Candidate Ifx-1 In Hidradenitis Suppurativa
08/11/2018 08:28
Brief: Inflarx NV Q2 Loss Per Share EUR 0.10
09/08/2018 12:28
U.S. STOCKS ON THE MOVE-Cisco, Netflix, AT&T, Wells Fargo, Citi
13/07/2018 18:50
U.S. STOCKS ON THE MOVE-Wells Fargo, Citi, Netflix, AT&T, Auris, ShiftPixy, Ingredion
13/07/2018 17:23
Brief: InflaRx Receives IND Approval From FDA To Start Phase II Clinical Trial Of IFX-1
28/06/2018 12:34
Brief: Inflarx N.V. Reports Q1 Loss Per Share Eur 0.40
17/05/2018 12:33
Brief: Inflarx Announces Pricing Of Primary And Secondary Offering Of Common Shares
04/05/2018 02:06
IFR's upcoming US IPOs, follow-ons + convertibles
03/05/2018 18:42
Brief: Inflarx NV Files For Offering Of Up To 1.5 Mln Common Shares
02/05/2018 12:19
U.S. RESEARCH ROUNDUP- Darden Restaurants, Fitbit, Paychex
02/04/2018 08:12
Brief: InflaRx Full Year 2017 Financial & Operating Results
29/03/2018 12:54
Brief: Inflarx Announces First Patient Enrolled In Phase Iib Trial With Lead Candidate Ifx-1 In Hidradenitis Suppurativa
08/03/2018 14:47
Brief: Inflarx Receives IND Acceptance To Proceed With A Phase IIB Trial With Lead Candidate IFX-1 In Hidradenitis Suppurativa
09/01/2018 13:56
Brief: Ra Capital Management Reports 12.3 Pct Passive Stake In Inflarx Nv
11/12/2017 21:32